ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Internal Medicine

Top Internal Medicine Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ALEXANDER RODI DO

Internal Medicine

288

$12.5K

129
98 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

39%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $56

OSAMA ELSHAZLY M.D.

Internal Medicine

15,407

$998K

329
224 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

31%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $56

JEFFERY KELLEY MD

Internal Medicine

8,945

$334K

398
241 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

38%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$37
Average prescription price

Avg: $56

ENRIQUE PELAYO MD

Internal Medicine

4,921

$335K

134
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $56

NADARAJAH NIRMALAN MD

Internal Medicine

13,528

$702K

423
292 are 65+

22%
patients receiving schedule two controlled substances

Avg: 5%

26%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $56

MURALI KRISHNA MADDIPATI M.D.,

Internal Medicine

5,850

$303K

210
138 are 65+

14%
patients receiving schedule two controlled substances

Avg: 5%

28%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $56

NAVID SYED M.D.

Internal Medicine

644

$21.6K

292
203 are 65+

17%
patients receiving schedule two controlled substances

Avg: 5%

27%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 25%

$34
Average prescription price

Avg: $56

OLOLADE REIS M.D.

Internal Medicine

2,050

$187K

67
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

34%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$91
Average prescription price

Avg: $56

MICHAEL ASKOWITZ M.D.

Internal Medicine

14,282

$295K

278
216 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

27%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 25%

$21
Average prescription price

Avg: $56

MICHAEL UKAEGBU MD

Internal Medicine

3,366

$149K

111
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

31%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $56

JOHN GIRARD MD

Internal Medicine

675

$27.3K

54
26 are 65+

44%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$40
Average prescription price

Avg: $56

ANANTHI JEYABARATH MD

Internal Medicine

9,841

$483K

205
183 are 65+

26%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $56

FELIX SOSA MD

Internal Medicine

3,932

$352K

147
104 are 65+

28%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$90
Average prescription price

Avg: $56

OWEN SMITH M.D.

Internal Medicine

9,905

$581K

304
241 are 65+

19%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $56

FAIAZ RASUL M.D.

Internal Medicine

6,405

$500K

232
145 are 65+

25%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$78
Average prescription price

Avg: $56

SHAUN LAURIE M.D.

Internal Medicine

44,467

$2.98M

971
709 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $56

JEFFREY LESTER MD

Internal Medicine

7,231

$348K

236
102 are 65+

28%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $56

BOGDAN MALISZEWSKI MD

Internal Medicine

12,050

$522K

353
234 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

28%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $56

VORBES ALEGER M.D.

Internal Medicine

31,199

$2.04M

593
458 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

27%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $56

JOSE TURRO M.D.

Internal Medicine

1,697

$63.1K

69
37 are 65+

22%
patients receiving schedule two controlled substances

Avg: 5%

29%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$37
Average prescription price

Avg: $56

SYED ZAIDI MD FACP

Internal Medicine

7,483

$309K

564
378 are 65+

23%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$41
Average prescription price

Avg: $56

FERDINAND BUMAGAT MD

Internal Medicine

9,003

$624K

294
193 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

30%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$69
Average prescription price

Avg: $56

NISCHAL REDDY MD

Internal Medicine

432

$5,502

252
178 are 65+

29%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 25%

$13
Average prescription price

Avg: $56

DAVID ESCHELBACHER M.D.

Internal Medicine

29,623

$1.62M

475
352 are 65+

18%
patients receiving schedule two controlled substances

Avg: 5%

35%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $56

ERNST MICHEL MD

Internal Medicine

3,565

$236K

170
97 are 65+

18%
patients receiving schedule two controlled substances

Avg: 5%

31%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank